September 2018

Table of Contents


Cover Story

The Case for Continued Innovation: Novel Amorphous Solid Dispersion Technologies for an Increasing Insoluble Drug Problem

By Scott V. Jermain, Pharm.D., The University of Texas at Austin; Dave Miller, Ph.D., DisperSol Technologies, LLC; Robert O. Williams III, Ph.D., The University of Texas at Austin

A high percentage of drugs in development are poorly water soluble, so new tools are needed to address this critical problem.


PharmSci 360: Countdown to Washington, D.C.

AAPS PharmSci 360 is just nine weeks away. See what this brand new meeting has to offer.

President's Report

Immuno-Oncology Takes Off

By Christopher R. McCurdy, Ph.D., FAAPS, President

Pharmaceutical Science Update 

U.S. Regulatory News

Regulatory Developments

AAPS Publications

Pharmaceutical Additive Manufacturing

An AAPS PharmSciTech mini-review on 3D printing processes.

AAPS eLearning

How Much Do You Know about Formulation?

Take our Quiz!

Professional Development

Virtual Teams: The Four Rights

Virtual teams are becoming the new normal in business life. Are we setting them up for success?

Guidance Comments Summaries

AAPS Community Provides Comments to WHO for Revised Guidance on Dissolution

Student Chapter Focus

University of California, San Francisco

Did You Know?

AAPS Experts in the Media


2018 AAPS Election Results

Events Calendar